Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Behavior, site use and demographics of shortfin devil rays, Mobula kuhlii, at a newly-discovered cleaning area in South Africa.

Autor: Carpenter, M. M., Perryman, R. J. Y., Marshall, A. D., Griffiths, C. L.

Publikováno v: Marine Biology; Jun2024, Vol. 171 Issue 6, p1-14, 14p

Dust grains fall from Saturn’s D-ring into its equatorial upper atmosphere

Autor: Mitchell, D. G., Perry, M. E., Hamilton, D. C., Westlake, J. H., Kollmann, P., Smith, H. T., Carbary, J. F., Waite, J. H., Perryman, R., Hsu, H.-W., Wahlund, J.-E., Morooka, M. W., Hadid, L. Z., Persoon, A. M., Kurth, W. S.

Publikováno v: Science, 2018 Oct 01. 362(6410), 50-50.

Externí odkaz: https://www.jstor.org/stable/26568280

Distinct Capabilities in NAD Metabolism Mediate Resistance to NAMPT Inhibition in Glioblastoma.

Autor: Perryman R; John Fulcher Neuro-Oncology Laboratory, Imperial College London, London W12 0NN, UK., Chau TW; John Fulcher Neuro-Oncology Laboratory, Imperial College London, London W12 0NN, UK., De-Felice J; John Fulcher Neuro-Oncology Laboratory, Imperial College London, London W12 0NN, UK., O'Neill K; John Fulcher Neuro-Oncology Laboratory, Imperial College London, London W12 0NN, UK., Syed N; John Fulcher Neuro-Oncology Laboratory, Imperial College London, London W12 0NN, UK.

Publikováno v: Cancers [Cancers (Basel)] 2024 May 29; Vol. 16 (11). Date of Electronic Publication: 2024 May 29.

Inhibition of the angiotensin II type 2 receptor AT 2 R is a novel therapeutic strategy for glioblastoma.

Autor: Perryman R; John Fulcher Molecular Neuro-Oncology Laboratory, Department Brain Sciences, Imperial College, London, United Kingdom., Renziehausen A; John Fulcher Molecular Neuro-Oncology Laboratory, Department Brain Sciences, Imperial College, London, United Kingdom., Shaye H; Department of Chemistry, University of Southern California, Los Angeles, CA 90089.; Bridge Institute, University of Southern California, Los Angeles, CA 90089., Kostagianni AD; Department of Chemistry, University of Ioannina, Ioannina, Greece., Tsiailanis AD; Department of Chemistry, University of Ioannina, Ioannina, Greece., Thorne T; Department of Computer Science, University of Surrey, Surrey, United Kingdom., Chatziathanasiadou MV; John Fulcher Molecular Neuro-Oncology Laboratory, Department Brain Sciences, Imperial College, London, United Kingdom.; Department of Chemistry, University of Ioannina, Ioannina, Greece., Sivolapenko GB; Laboratory of Pharmacokinetics, Department of Pharmacy, University of Patras, Patras, Greece., El Mubarak MA; Laboratory of Pharmacokinetics, Department of Pharmacy, University of Patras, Patras, Greece., Han GW; Bridge Institute, University of Southern California, Los Angeles, CA 90089., Zarzycka B; Bridge Institute, University of Southern California, Los Angeles, CA 90089.; Division of Medicinal Chemistry, Amsterdam Institute for Molecules, Medicines and Systems, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands., Katritch V; Bridge Institute, University of Southern California, Los Angeles, CA 90089.; Department of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA 90089., Lebon G; Institut de Génomique Fonctionnelle, University of Montpellier, CNRS, INSERM, Montpellier, France., Lo Nigro C; Department of Oncology, Ospedale San Croce e Carle, Cuneo, Italy., Lattanzio L; Department of Oncology, Ospedale San Croce e Carle, Cuneo, Italy., Morse SV; John Fulcher Molecular Neuro-Oncology Laboratory, Department Brain Sciences, Imperial College, London, United Kingdom.; Department of Bioengineering, Imperial College London, London, United Kingdom., Choi JJ; Department of Bioengineering, Imperial College London, London, United Kingdom., O'Neill K; John Fulcher Molecular Neuro-Oncology Laboratory, Department Brain Sciences, Imperial College, London, United Kingdom.; Department of Neurosurgery, Charing Cross Hospital, London, United Kingdom., Kanaki Z; Centre for Basic Research, Biomedical Research Foundation of the Academy of Athens, Greece., Klinakis A; Centre for Basic Research, Biomedical Research Foundation of the Academy of Athens, Greece., Crook T; John Fulcher Molecular Neuro-Oncology Laboratory, Department Brain Sciences, Imperial College, London, United Kingdom., Cherezov V; Department of Chemistry, University of Southern California, Los Angeles, CA 90089.; Bridge Institute, University of Southern California, Los Angeles, CA 90089., Tzakos AG; Department of Chemistry, University of Ioannina, Ioannina, Greece.; University Research Center of Ioannina, Institute of Materials Science and Computing, Ioannina, Greece.; Biomedical and Analytical Center (BAC), University of Ioannina, Ioannina, Greece., Syed N; John Fulcher Molecular Neuro-Oncology Laboratory, Department Brain Sciences, Imperial College, London, United Kingdom.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Aug 09; Vol. 119 (32), pp. e2116289119. Date of Electronic Publication: 2022 Aug 02.